CoV2ID: Detection-and-Therapeutics-Oligo-Database-for-SARS-CoV-2

Here we describe the CoV2ID, a free database built to facilitate the evaluation of molecular methods for detection of SARS-CoV-2 and treatment of COVID-19. The database evaluates the available oligonucleotide sequences (PCR primers, RT-qPCR probes, etc.) CoV2ID is an open-access, curated database of oligonucleotide sequences, including primers, probes, and siRNAs, designed for the detection and therapeutic targeting of SARS-CoV-2. Developed in response to the COVID-19 pandemic, CoV2ID systematically compiles and annotates oligonucleotide data from published literature, providing researchers and clinical laboratories with a centralized resource for molecular diagnostics and therapeutic design. The database was developed as part of an EU-funded initiative and supports the rapid identification of validated oligonucleotide candidates for PCR-based detection systems and RNA-targeting therapeutics. CoV2ID is part of the broader VirusScope platform, a suite of genomic databases for highly infectious viruses. 📄 Citation: Carneiro J, Gomes C, Couto C, Pereira F. CoV2ID: Detection and Therapeutics Oligo Database for SARS-CoV-2. bioRxiv 2020. https://doi.org/10.1101/2020.04.19.048991